Home > Food & Beverages > Proteins > Alternative Proteins > Casein Peptone Market

Casein Peptone Market Trends

Report ID: GMI5965
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Casein Peptone Market Trends

The shifting trend towards plant-based alternatives in various industries, including pharmaceuticals, biotechnology, and food to pave way for the market growth. The increasing adoption of vegan and vegetarian diets is contributing to the demand for animal-free alternatives. The number of vegans in the U.S. has increased by 600% from 2014 to 2017, and between 2018 to 2022 the number of vegans in the U.S. increased by 500%. This trend is driven by factors such as ethical considerations, sustainability concerns, and dietary preferences.

The manufacturers in the casein peptone market are exploring and developing plant-based or alternative protein sources to cater to this demand. Also, with the increasing demand for high-quality products, there is a growing emphasis on maintaining consistent quality standards in casein peptone production. Manufacturers are investing in advanced technologies and stringent quality control measures to ensure batch-to-batch consistency, purity, and reliability of their casein peptone products. This trend is particularly important in applications where reproducibility and reliability are critical, such as in biopharmaceutical production.

Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

The market size of casein peptone surpassed USD 392 million in 2022 and is estimated to reach more than USD 600 million by the end of 2032. With the growing demand for microbial testing & research activities in various industries such as pharmaceuticals, biotechnology, and food, there is an increasing need for high-quality casein peptone to support microbial growth and identification.

Technical grade casein peptone segment will cross USD 450 million by 2032, as the product is extensively used in culture media for the isolation and identification of microorganisms in clinical diagnostics and research laboratories.

The U.S. dominated North America market with a revenue of USD 55.90 million in 2022 and it will o expand at a significant pace from 2023 to 2032, backed by the rapid development and increased investment in the biopharmaceutical sector in the region.

Apollo Scientific Ltd, Amyl Media Pvt Ltd, Neogen Corporation, Merck KGaA, MP Biomedicals LLC, Carl Roth Gmbh & Co. KG, and Azelis Americas, LLC.